Pharmaceutical companies that want to use influencers to promote their products should provide compliance training on US Food and Drug Administration promotional requirements, ensure the content conveys the typical patient experience in line with a drug’s labeling, and set expectations about the need for marketing, legal and regulatory review of content before posting.
Those are some of the rules of the road suggested by regulatory, advertising and legal experts at panel discussions on influencers and social media during the Drug Information Association’s recent...